Skip to content

The Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Catheter-Related Bladder Discomfort in Patients Undergoing Transurethral Enucleation and Resection of the Prostate: a single-center, randomized controlled clinical trial

The Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Catheter-Related Bladder Discomfort in Patients Undergoing Transurethral Enucleation and Resection of the Prostate: a single-center, randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085914
Enrollment
Unknown
Registered
2024-06-21
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-Related Bladder Discomfort

Interventions

Transcutaneous electric nerve stimulation (TEAS) Group:Selected "Yinjiao" (RN7), "Zhongji" (RN3) and bilateral "Ciliao" (BL32) for electrical stimulation of acupoints, with stimulation frequency alter
Control Group:Electrode pads were attached to the "Yinjiao" (RN7), "Zhongji" (RN3) and bilateral "Ciliao" (BL32) , but no electrical stimulation was performed.

Sponsors

Qingdao Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosis of benign prostatic hyperplasia and elective TUERP; (2) Age 18-80 years old; (3) ASA class I-III; (4) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Contraindications to transcutaneous electrical acupoint stimulation, including skin allergy, infection, and carrying a pacemaker; (2) History of multiple acupuncture or transcutaneous electrical acupoint stimulation treatments; (3) Mental illness unable to cooperate; (4) Impaired bladder activity due to bladder disease.

Design outcomes

Primary

MeasureTime frame
Incidence and severity of CRBD when patients leave the PACU;

Secondary

MeasureTime frame
Incidence and severity of CRBD when patients are admitted to the PACU;Incidence and severity of CRBD at 24 hours postoperatively;Incidence and severity of CRBD at 24 hours postoperatively;Visual analogue scale, VAS;Postoperative Nausea and Vomiting, PONV;15-item Quality of Recovery, QoR-15;

Countries

China

Contacts

Public ContactShoushi Wang

Qingdao Central Hospital

wangshoushi1226@126.com+86 185 6185 6159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026